Streetbeat News

Price Targets

PCRX

Pacira BioSciences (NASDAQ:PCRX) has received mixed analyst ratings, with a notable decrease in the average 12-month price target from $41.29 to $30.36. Analysts have adjusted their ratings and price targets, reflecting varied expectations for the company's future performance. Despite a strong net margin and effective debt management, Pacira's revenue growth lags behind industry peers.

Portfolio Pulse from Benzinga Insights

September 24, 2024 | 4:00 pm

EL

Estee Lauder Cos (NYSE:EL) has received mixed analyst ratings over the past three months, with a recent average 12-month price target of $120.91, down from $137.97. Analysts have adjusted their ratings and price targets in response to market dynamics, with some maintaining bullish stances while others have lowered their expectations. Estee Lauder's financial performance shows a revenue growth rate of 7.26% and challenges in debt management with a high debt-to-equity ratio.

Portfolio Pulse from Benzinga Insights

September 24, 2024 | 4:00 pm

HD

LOW

Oppenheimer analyst Brian Nagel upgraded Lowe's Companies Inc (NYSE:LOW) from Perform to Outperform, raising the price target from $230 to $305. The upgrade is based on expected demand improvements in the home improvement sector due to moderating lending rates, with benefits likely to be seen starting in 2025. Lowe's shares rose 0.63% following the announcement.

Portfolio Pulse from Priya Nigam

September 24, 2024 | 3:58 pm

STZ

Barclays analyst Lauren Lieberman has maintained an Overweight rating on Constellation Brands (NYSE:STZ) and raised the price target from $295 to $309.

Portfolio Pulse from Benzinga Newsdesk

September 24, 2024 | 3:53 pm

HSY

Barclays analyst Andrew Lazar maintains an Equal-Weight rating on Hershey (NYSE:HSY) but lowers the price target from $204 to $202.

Portfolio Pulse from Benzinga Newsdesk

September 24, 2024 | 3:50 pm

PCRX

Jefferies analyst Glen Santangelo maintains a Buy rating on Pacira BioSciences and raises the price target from $15 to $18.

Portfolio Pulse from Benzinga Newsdesk

September 24, 2024 | 3:43 pm

CYBR

Jefferies analyst Joseph Gallo maintains a Buy rating on CyberArk Software and raises the price target from $315 to $330.

Portfolio Pulse from Benzinga Newsdesk

September 24, 2024 | 3:40 pm

CRWD

Jefferies analyst Joseph Gallo maintains a Buy rating on CrowdStrike Holdings and raises the price target from $315 to $345.

Portfolio Pulse from Benzinga Newsdesk

September 24, 2024 | 3:37 pm

CHKP

Jefferies analyst Joseph Gallo maintains a Buy rating on Check Point Software and raises the price target from $210 to $225.

Portfolio Pulse from Benzinga Newsdesk

September 24, 2024 | 3:34 pm

EL

DA Davidson analyst Linda Bolton Weiser maintains a Buy rating on Estee Lauder Cos (NYSE:EL) with a price target of $130.

Portfolio Pulse from Benzinga Newsdesk

September 24, 2024 | 3:26 pm